• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fbxw7缺失通过Yap积累加速Kras驱动的胰腺肿瘤发生。

Fbxw7 Deletion Accelerates Kras-Driven Pancreatic Tumorigenesis via Yap Accumulation.

作者信息

Zhang Qiang, Zhang Yaqing, Parsels Joshua D, Lohse Ines, Lawrence Theodore S, Pasca di Magliano Marina, Sun Yi, Morgan Meredith A

机构信息

Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

出版信息

Neoplasia. 2016 Nov;18(11):666-673. doi: 10.1016/j.neo.2016.08.009. Epub 2016 Oct 18.

DOI:10.1016/j.neo.2016.08.009
PMID:27764699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5071541/
Abstract

Pancreatic cancers driven by KRAS mutations require additional mutations for tumor progression. The tumor suppressor FBXW7 is altered in pancreatic cancers, but its contribution to pancreatic tumorigenesis is unknown. To determine potential cooperation between Kras mutation and Fbxw7 inactivation in pancreatic tumorigenesis, we generated P48-Cre;LSL-Kras;Fbxw7 (KFC) compound mice. We found that KFC mice displayed accelerated tumorigenesis: all mice succumbed to pancreatic ductal adenocarcinoma (PDA) by 40 days of age, with PDA onset occurring by 2 weeks of age. PDA in KFC mice was preceded by earlier onset of acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia (PanIN) lesions, and associated with chromosomal instability and the accumulation of Fbxw7 substrates Yes-associated protein (Yap), c-Myc, and Notch. Using KFC and FBXW7-deficient human pancreatic cancer cells, we found that Yap silencing attenuated growth promotion by Fbxw7 deletion. Our data demonstrate that Fbxw7 is a potent suppressor of Kras-induced pancreatic tumorigenesis due, at least in part, to negative regulation of Yap.

摘要

由KRAS突变驱动的胰腺癌需要额外的突变才能实现肿瘤进展。肿瘤抑制因子FBXW7在胰腺癌中发生改变,但其对胰腺肿瘤发生的作用尚不清楚。为了确定Kras突变与Fbxw7失活在胰腺肿瘤发生中的潜在协同作用,我们构建了P48-Cre;LSL-Kras;Fbxw7(KFC)复合小鼠。我们发现KFC小鼠表现出加速的肿瘤发生:所有小鼠在40日龄时均死于胰腺导管腺癌(PDA),PDA在2周龄时开始出现。KFC小鼠的PDA之前出现更早的腺泡-导管化生(ADM)和胰腺上皮内瘤变(PanIN)病变,并与染色体不稳定性以及Fbxw7底物Yes相关蛋白(Yap)、c-Myc和Notch的积累有关。使用KFC和FBXW7缺陷的人胰腺癌细胞,我们发现Yap沉默减弱了Fbxw7缺失对生长的促进作用。我们的数据表明,Fbxw7是Kras诱导的胰腺肿瘤发生的有效抑制因子,至少部分原因是对Yap的负调控。

相似文献

1
Fbxw7 Deletion Accelerates Kras-Driven Pancreatic Tumorigenesis via Yap Accumulation.Fbxw7缺失通过Yap积累加速Kras驱动的胰腺肿瘤发生。
Neoplasia. 2016 Nov;18(11):666-673. doi: 10.1016/j.neo.2016.08.009. Epub 2016 Oct 18.
2
Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.Krüppel 样因子 5 在胰腺导管腺癌中增加,促进增殖、腺泡到导管化生、胰腺上皮内瘤变和肿瘤生长在小鼠中。
Gastroenterology. 2018 Apr;154(5):1494-1508.e13. doi: 10.1053/j.gastro.2017.12.005. Epub 2017 Dec 15.
3
Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.Fbxw7是一种独立的预后标志物,通过调节YAP丰度诱导肝癌细胞凋亡和生长停滞。
Mol Cancer. 2014 May 17;13:110. doi: 10.1186/1476-4598-13-110.
4
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.激活素受体1B型缺失加速KRAS激活小鼠导管内乳头状黏液性肿瘤的发展。
Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.
5
The emerging roles of F-box proteins in pancreatic tumorigenesis.F-box蛋白在胰腺肿瘤发生中的新作用。
Semin Cancer Biol. 2016 Feb;36:88-94. doi: 10.1016/j.semcancer.2015.09.004. Epub 2015 Sep 16.
6
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.YAP1和TAZ通过直接上调JAK-STAT3信号通路来控制小鼠胰腺癌的起始。
Gastroenterology. 2016 Sep;151(3):526-39. doi: 10.1053/j.gastro.2016.05.006. Epub 2016 May 20.
7
Inactivation of Attenuated Pancreatic Tumorigenesis in Mice.抑制造模组鼠胰腺肿瘤生成。
Cancer Res Commun. 2022 Dec 12;2(12):1601-1616. doi: 10.1158/2767-9764.CRC-22-0106. eCollection 2022 Dec.
8
RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.RAGE 基因缺失抑制导管肿瘤的发生和发展,并延长胰腺癌小鼠模型的生存期。
J Gastrointest Surg. 2012 Jan;16(1):104-12; discussion 112. doi: 10.1007/s11605-011-1754-9. Epub 2011 Nov 4.
9
Inactivation of HIPK2 attenuates KRAS activity and prevents pancreatic tumorigenesis.抑制 HIPK2 可减弱 KRAS 的活性,防止胰腺肿瘤的发生。
J Exp Clin Cancer Res. 2024 Sep 28;43(1):265. doi: 10.1186/s13046-024-03189-3.
10
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.突变型 KRAS 下游的转录调节因子 YAP 对于胰腺导管腺癌的肿瘤进展是必需的。
Sci Signal. 2014 May 6;7(324):ra42. doi: 10.1126/scisignal.2005049.

引用本文的文献

1
YAP/TAZ Promote GLUT1 Expression and Are Associated with Prognosis in Endometrial Cancer.YAP/TAZ促进葡萄糖转运蛋白1(GLUT1)表达并与子宫内膜癌的预后相关。
Cancers (Basel). 2025 Aug 1;17(15):2554. doi: 10.3390/cancers17152554.
2
The Hippo signaling pathway modulates pancreatic tissue homeostasis.河马信号通路调节胰腺组织稳态。
Cell Death Discov. 2025 Jul 24;11(1):343. doi: 10.1038/s41420-025-02636-0.
3
AT101 Suppresses Gastrointestinal Stromal Tumor Growth and Promotes Apoptosis via YAP/TAZ-CCND1 and FBXW7-MCL1 Axes.

本文引用的文献

1
Genomic analyses identify molecular subtypes of pancreatic cancer.基因组分析确定了胰腺癌的分子亚型。
Nature. 2016 Mar 3;531(7592):47-52. doi: 10.1038/nature16965. Epub 2016 Feb 24.
2
FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.FBXW7通过XRCC4的K63连接多聚泛素化促进非同源末端连接。
Mol Cell. 2016 Feb 4;61(3):419-433. doi: 10.1016/j.molcel.2015.12.010. Epub 2016 Jan 7.
3
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.ERK激酶使胰腺癌中的肿瘤抑制因子FBW7磷酸化并使其不稳定。
AT101通过YAP/TAZ-CCND1和FBXW7-MCL1轴抑制胃肠道间质瘤生长并促进细胞凋亡。
Ann Surg Oncol. 2025 Mar 27. doi: 10.1245/s10434-025-17247-3.
4
FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects.FBXW7在胃肠道癌症中的研究:从分子机制到治疗前景
Front Pharmacol. 2024 Dec 18;15:1505027. doi: 10.3389/fphar.2024.1505027. eCollection 2024.
5
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.差异性miRNA和蛋白质表达揭示了miR-1285及其靶标TGM2和CDH-1,以及CD166和S100A13作为糖尿病和胰腺腺癌患者潜在的新型生物标志物。
Cancers (Basel). 2024 Jul 31;16(15):2726. doi: 10.3390/cancers16152726.
6
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.体内 CRISPR 筛选揭示 SCAF1 和 USP15 是胰腺癌的驱动因子。
Nat Commun. 2024 Jun 20;15(1):5266. doi: 10.1038/s41467-024-49450-3.
7
Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases.Cullin-RING连接酶在调节自身免疫性疾病中的潜在作用进展
Front Immunol. 2023 Mar 17;14:1125224. doi: 10.3389/fimmu.2023.1125224. eCollection 2023.
8
Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via the cAMP-CREB axis.上调的GPRC5A破坏Hippo信号通路,通过cAMP-CREB轴促进胰腺癌细胞的增殖和迁移。
Discov Oncol. 2023 Feb 3;14(1):17. doi: 10.1007/s12672-023-00626-1.
9
FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies.FBXW7与癌症特征:潜在机制与前瞻性策略
Front Oncol. 2022 Apr 19;12:880077. doi: 10.3389/fonc.2022.880077. eCollection 2022.
10
Clinical significance of FBXW7 loss of function in human cancers.FBXW7 功能丧失在人类癌症中的临床意义。
Mol Cancer. 2022 Mar 26;21(1):87. doi: 10.1186/s12943-022-01548-2.
Cell Res. 2015 May;25(5):561-73. doi: 10.1038/cr.2015.30. Epub 2015 Mar 10.
4
Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.Fbw7泛素连接酶的肿瘤抑制作用:机制与机遇
Cancer Cell. 2014 Oct 13;26(4):455-64. doi: 10.1016/j.ccell.2014.09.013.
5
Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ, and β cells.Fbw7的缺失将成年胰腺导管细胞重编程为α、δ和β细胞。
Cell Stem Cell. 2014 Aug 7;15(2):139-53. doi: 10.1016/j.stem.2014.06.019.
6
Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation.染色体不稳定是造血干细胞功能障碍和与Fbw7介导的细胞周期蛋白E调控受损相关的淋巴样肿瘤的基础。
Mol Cell Biol. 2014 Sep;34(17):3244-58. doi: 10.1128/MCB.01528-13. Epub 2014 Jun 23.
7
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.Yap1 激活可绕过胰腺癌中的致癌 Kras 成瘾。
Cell. 2014 Jul 3;158(1):185-197. doi: 10.1016/j.cell.2014.06.003. Epub 2014 Jun 19.
8
Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.Fbxw7是一种独立的预后标志物,通过调节YAP丰度诱导肝癌细胞凋亡和生长停滞。
Mol Cancer. 2014 May 17;13:110. doi: 10.1186/1476-4598-13-110.
9
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.突变型 KRAS 下游的转录调节因子 YAP 对于胰腺导管腺癌的肿瘤进展是必需的。
Sci Signal. 2014 May 6;7(324):ra42. doi: 10.1126/scisignal.2005049.
10
Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer.YAP 和 c-Myc 之间的相互作用对肝癌的致癌作用至关重要。
Biochem Biophys Res Commun. 2013 Sep 20;439(2):167-72. doi: 10.1016/j.bbrc.2013.08.071. Epub 2013 Aug 28.